Skip to main content
. 2016 Nov 10;9:6897–6907. doi: 10.2147/OTT.S120062

Figure 4.

Figure 4

Survival curves of patients in the LAM and ADV groups.

Notes: (A) Overall survival and (B) recurrence-free survival between the LAM and ADV groups before propensity score matching. (C) Overall survival and (D) recurrence-free survival between the LAM and ADV groups after propensity score matching.

Abbreviations: ADV, adefovir dipivoxil; LAM, lamivudine.